New Hampshire Oncology-Hematology, PA — Laconia, New Hampshire

New Hampshire Oncology-Hematology, PA is a clinical research site located in Laconia, New Hampshire, United States 03246.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

New Hampshire Oncology-Hematology, PA has participated in 1 clinical trials.

Therapeutic areas: Breast Cancer.

Sponsors: Dana-Farber Cancer Institute.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Laconia

Browse all research sites in New Hampshire · View every site in Laconia

• Lakes Region General Hospital
• LRGHealthcare-Lakes Region General Hospital
• Investigational Site
• New Hampshire Oncology Hematology-P.A.
• Novartis Investigative Site
• New Hampshire Oncology and Hematology
• New Hampshire Oncology Hematology - Laconia
• Lakes Regional General Healthcare
• Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New Hampshire Oncology-Hematology, PA?

New Hampshire Oncology-Hematology, PA has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New Hampshire Oncology-Hematology, PA conducted?

New Hampshire Oncology-Hematology, PA has 1 clinical trials on record. Their work covers Breast Cancer.

Is New Hampshire Oncology-Hematology, PA accredited by Crixeo Clinical Trials?

New Hampshire Oncology-Hematology, PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New Hampshire Oncology-Hematology, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.